Enovis Corp ENOV
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Enovis to Present at the Annual Jefferies Global Healthcare Concerence in London
ENOVIS Announces Third Quarter 2026 Results
Enovis to Host Third Quarter 2026 Results Conference Call on November 5th
Enovis becomes first multi-registry industry sponsor of AAOS Registry Program
eCential Robotics Announces Binding Offer from Enovis
Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics
Enovis to Participate in the 2026 Wells Fargo Healthcare Conference
Trading Information
- Previous Close Price
- $27.92
- Day Range
- $27.19–28.27
- 52-Week Range
- $16.70–31.67
- Bid/Ask
- $26.86 / $28.78
- Shares Outstanding
- 57.69M
- Market Cap
- $1.57B
- Volume/Avg
- 1M / 2M
Key Statistics
- Price/Earnings (Normalized)
- 7.83
- Price/Sales
- 0.68
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 7,802
- Website
- https://www.enovis.com
Valuation
Metric | ENOV |
|---|---|
Price/Earnings (Normalized) | 7.83 |
Price/Book Value | 1.05 |
Price/Sales | 0.68 |
Price/Cash Flow | 5.82 |
Price/Earnings
ENOV
Financial Strength
Metric | ENOV |
|---|---|
Quick Ratio | 0.76 |
Current Ratio | 2.15 |
Interest Coverage | −14.52 |
Quick Ratio
ENOV
Profitability
Metric | ENOV |
|---|---|
Return on Assets (Normalized) | 5.36% |
Return on Equity (Normalized) | 13.20% |
Return on Invested Capital (Normalized) | 7.85% |
Return on Assets
ENOV
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|<Tn^&Y | LOCK|<<@^ | $181B | |||
| Medtronic PLC MDT | LOCK|>?&#L@n | LOCK|?NHyb | $131B | |||
| Stryker Corp SYK | LOCK|^?$dMd? | LOCK|L! | $121B | |||
| Boston Scientific Corp BSX | LOCK|#CV@#>j | LOCK|<&LHq | $62B | |||
| Edwards Lifesciences Corp EW | LOCK|<xS^DB@L | LOCK|@>#z& | $61B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|$NmddK | LOCK|bP^ | $37B | |||
| DexCom Inc DXCM | LOCK|Ddggbl?% | LOCK|d##> | $31B | |||
| Koninklijke Philips NV ADR PHG | LOCK|h$ | LOCK|G& | $29B | |||
| Steris PLC STE | LOCK|gg$KQ! | LOCK|%r&rV | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|?V$z^##v | LOCK|J& | $19B |